Sybille Albrecht

Title: Sybille Albrecht: Innovator in Antibody Research

Introduction

Sybille Albrecht is a prominent inventor based in Dresden, Germany. She has made significant contributions to the field of biomedical research, particularly in the development of diagnostic and therapeutic methods involving antibodies. With a total of 3 patents, her work has had a notable impact on medical science.

Latest Patents

One of her latest patents is focused on the diagnostic and therapeutic use of antibodies against the urokinase receptor. This invention concerns a method and a reagent kit for detecting cells in a biological sample using a double-fluorescence technique. It also includes the diagnostic and therapeutic application of amino acid sequence-specific antibodies against the urokinase receptor, which have a high affinity for tumor cell-expressed receptors. Another significant patent involves the expression of signal-peptide-free staphylokinases. This invention relates to recombinant staphylokinase polypeptides with a plasminogen activator effect and details their production and use. The polypeptides are obtained by expressing DNA sequences that are free from signal-peptide-coding regions.

Career Highlights

Throughout her career, Sybille Albrecht has worked with notable companies such as Wilex AG and Medac Gesellschaft für Klinische Spezialpräparate mbH. Her experience in these organizations has allowed her to advance her research and contribute to innovative solutions in the medical field.

Collaborations

Sybille has collaborated with esteemed colleagues, including Bernhard Schlott and Karl-Heinz Guhrs. These partnerships have further enriched her research endeavors and have led to significant advancements in her field.

Conclusion

Sybille Albrecht's contributions to antibody research and her innovative patents highlight her role as a leading inventor in the biomedical field. Her work continues to influence diagnostic and therapeutic practices, showcasing the importance of innovation in healthcare.